Complementary in Medical Technology
Navigation Links
Complementary in Medical Technology
... smell suspicious should be tossed.
Energy Therapies -- A complementary Approach to Promote Well-Being
ROCHESTER, Minn. -- Energy ... Clinic Women's HealthSource .
Energy therapies are considered complementary and alternative health practices. Acupuncture is the best known, but ...
... of Kansai Medical University whose research investigated AHCC as a complementary therapy to pharmaceuticals in post-operative cancer patients along with ... said Fred Pescatore, M.D., M.P.H., of the Center for Integrative and complementary Medicine, and medical director for the U.S. AHCC Research Association in ...
... the medical use of Iomai's Travelers' Diarrhea vaccine will be highly complementary with Intercell's Japanese Encephalitis vaccine for which a Biologics ... Intercell's position as an innovative vaccine company and is highly complementary with its proprietary antigen identification and adjuvant vaccine ...
... TSEM , TASE: TSEM), a global specialty foundry leader, manufactures integrated circuits with geometries ranging from 1.0 to 0.13-micron and provides complementary technical services and design support. Tower, along with its fully owned U.S. subsidiary, Jazz Semiconductor, Inc., offers a broad range of process ...
... in a variety of clinical trials, develops patient-specific biological treatments in its cell biology laboratory, and provides a wealth of complementary care programs for patients. About Hoag Memorial Hospital Presbyterian Hoag Memorial Hospital Presbyterian is a 498-bed, not-for-profit, ...
... information, visit www.arizona.edu About Arizona Alzheimer's Consortium The Arizona Alzheimer's Consortium (AAC) capitalizes on the complementary resources of its seven member institutions to promote the scientific understanding and early detection of Alzheimer's disease and find effective ...
... comprehensive, patient-centered treatment model that fully integrates traditional, state-of-the-art medical treatments with scientifically-supported complementary and alternative therapies such as nutrition, naturopathy, psychological counseling, physical therapy and spiritual support to meet the special, ...
... topically to the area of pain, systemic exposure is minimized, and hence, systemic side effects appear to be minimal. Moreover, this approach may be complementary to systemic approaches. We are now in the midst of an additional randomized, controlled Phase 2b trial to confirm the safety and efficacy of topical ...
... novel medicines in the areas of hepatitis C and oncology. For the treatment of chronic hepatitis C, the Company is developing two potentially complementary agents, ANA598, a non-nucleoside polymerase inhibitor and ANA773, an oral inducer of endogenous interferons that acts via the TLR7 pathway. The ...
... Richard Becker, MD, director of the Duke Cardiovascular Thrombosis Center and lead author of the study. "TRA appears to work in a novel way that is complementary to current antiplatelet therapies," he further commented. Another important result from the Thrombin Receptor Antagonist Percutaneous Coronary ...
... that the transaction will not be completed, or if completed, not completed on a timely basis; the possibility that the acquisition of Indevus is not complementary to Endo; the potential that market segment growth will not follow historical patterns; general industry conditions and competition; business and ...
... therapeutics internally. In addition, the company collaborates with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product ...
... to significantly improve patients' quality of life," said Katie Hood, the Foundation's CEO. "Each one of our Pipeline Programs is a unique and complementary expression of our overarching mission -- identifying and enabling the critical ideas, teams and projects that will carry the field over the finish ...
... therapeutics internally. In addition, the company collaborates with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product ...
... to help clarify or validate other clinical findings. This test further strengthens our growing portfolio of proprietary, high-value diagnostics and complementary pharmaceutical products." IBS can be challenging to diagnose because it is a functional disease that is not associated with any visible abnormality ...
... companies, such as Baxter, GlaxoSmithKline (GSK), Merck Generics (part of Mylan Inc), UCB and Otsuka, as well as providing revenue streams, complementary products and critical mass. For further information, please visit Vectura's website at http://www.vectura.com Forward-Looking Statements This ...
... demonstrate the substantial anti-cancer effect of Angiolix, which we feel is comparable to Avastin yet achieved through a different and potentially complementary mechanism of action," stated Jeffrey B. Davis, President & CEO. "As stated previously, Access is actively seeking potential partners for the further ...
... health. As a central component of the MLP, the Molecular Libraries Probe Production Centers Network (MLPCN) is a collaborative research network with complementary abilities that will enable screening of diverse types of assays and generation of chemical probes to address a wide range of biological ....
... therapeutics internally. In addition, the company collaborates with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product ...
... therapeutics internally. In addition, the company collaborates with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product ...
... after their launch due to their efficacy and high price point. The widespread use of these agents will depend, in part, on their safety and the complementary use of new diagnosis techniques that would permit patients to be diagnosed in the early stages of the disease, when disease-modifying therapies ...
... of Kansai Medical University whose research investigated AHCC as a complementary therapy to pharmaceuticals in post-operative cancer patients along with ... said Fred Pescatore, M.D., M.P.H., of the Center for Integrative and complementary Medicine, and medical director for the U.S. AHCC Research Association in ...
Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
... Includes ANA598 and ANA773 Acting via Independent but Potentially complementary Mechanisms Conference Call Today at 2:00 PM PDT SAN ... treat hepatitis C, the TLR7 mechanism is independent from, and potentially complementary to, ANA598, Anadys' non-nucleoside HCV polymerase inhibitor currently in ...Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
... syringe formulation to be administered subcutaneously - Highly complementary fit with Shire's portfolio of specialist products; FIRAZYR expected to ... acquisition of Jerini would bring to Shire a new drug that is highly complementary to our HGT portfolio, which we have been developing since 2005 as part of ...... the medical use of Iomai's Travelers' Diarrhea vaccine will be highly complementary with Intercell's Japanese Encephalitis vaccine for which a Biologics ... Intercell's position as an innovative vaccine company and is highly complementary with its proprietary antigen identification and adjuvant vaccine ...
... TSEM , TASE: TSEM), a global specialty foundry leader, manufactures integrated circuits with geometries ranging from 1.0 to 0.13-micron and provides complementary technical services and design support. Tower, along with its fully owned U.S. subsidiary, Jazz Semiconductor, Inc., offers a broad range of process ...
... in a variety of clinical trials, develops patient-specific biological treatments in its cell biology laboratory, and provides a wealth of complementary care programs for patients. About Hoag Memorial Hospital Presbyterian Hoag Memorial Hospital Presbyterian is a 498-bed, not-for-profit, ...
... information, visit www.arizona.edu About Arizona Alzheimer's Consortium The Arizona Alzheimer's Consortium (AAC) capitalizes on the complementary resources of its seven member institutions to promote the scientific understanding and early detection of Alzheimer's disease and find effective ...
Salvacyl(R), Developed by Debiopharm, is Launched in two European Countries
... Mauvernay, President and Founder of Debiopharm Group. "We can now offer people suffering from this controversial disorder an alternative and a complementary treatment to surgical and currently used chemical castrations, as well as to other types of medication." Salvacyl(R) is registered in seven ...... comprehensive, patient-centered treatment model that fully integrates traditional, state-of-the-art medical treatments with scientifically-supported complementary and alternative therapies such as nutrition, naturopathy, psychological counseling, physical therapy and spiritual support to meet the special, ...
Takeda to Revise Timing of Alogliptin and Alogliptin/ACTOS MAA Filings in Europe
... owned U.S. subsidiary, Takeda San Diego, Inc. is a dipeptidyl peptidase IV (DPP-4) inhibitor for the treatment of type 2 diabetes. By providing complementary mechanisms of action, alogliptin/ACTOS targets the core defects of type 2 diabetes - insulin resistance (when the body does not efficiently use the ...... topically to the area of pain, systemic exposure is minimized, and hence, systemic side effects appear to be minimal. Moreover, this approach may be complementary to systemic approaches. We are now in the midst of an additional randomized, controlled Phase 2b trial to confirm the safety and efficacy of topical ...
... novel medicines in the areas of hepatitis C and oncology. For the treatment of chronic hepatitis C, the Company is developing two potentially complementary agents, ANA598, a non-nucleoside polymerase inhibitor and ANA773, an oral inducer of endogenous interferons that acts via the TLR7 pathway. The ...
Addrenex Pharmaceuticals Reports Positive Results in Second Phase 3 Study of ADHD Medication
... suggest that Clonicel is an effective therapy for ADHD when used alone, and now we have evidence from a second study that Clonicel also has a complementary effect when used with stimulants," said Moise Khayrallah, Ph.D., CEO of Addrenex Pharmaceuticals. "In children who are not receiving optimal benefit ...InnoCentive and Nature Publishing Group Announce Partnership to Facilitate Open Innovation
... development activities with reduced budgets and resources. The partnership of NPG and InnoCentive will accelerate the uptake of open innovation as a complementary business model that has particular appeal during a global economic downturn. " Nature is one of the most well-known scientific publications on ...... Richard Becker, MD, director of the Duke Cardiovascular Thrombosis Center and lead author of the study. "TRA appears to work in a novel way that is complementary to current antiplatelet therapies," he further commented. Another important result from the Thrombin Receptor Antagonist Percutaneous Coronary ...
FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
... that the transaction will not be completed, or if completed, not completed on a timely basis; the possibility that the acquisition of Indevus is not complementary to Endo; the potential that market segment growth will not follow historical patterns; general industry conditions and competition; business and ...CyberKnife Radiosurgery for Lung Cancer Sees Increased Interest and Continued Rapid Growth
... from the forward-looking statements we make include: market acceptance of products; competing products, the combination of our products with complementary technology; and other risks detailed from time to time under the heading "Risk Factors" in our report on Form 10-K for the 2008 fiscal year, as ...... that the transaction will not be completed, or if completed, not completed on a timely basis; the possibility that the acquisition of Indevus is not complementary to Endo; the potential that market segment growth will not follow historical patterns; general industry conditions and competition; business and ...
Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration
... that the transaction will not be completed, or if completed, not completed on a timely basis; the possibility that the acquisition of Indevus is not complementary to Endo; the potential that market segment growth will not follow historical patterns; general industry conditions and competition; business and ...ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
... novel medicines in the areas of hepatitis C and oncology. For the treatment of chronic hepatitis C, the Company is developing two potentially complementary agents, ANA598, a non-nucleoside polymerase inhibitor and ANA773, an oral TLR7 agonist prodrug. The Company is also developing ANA773 for the ...Gene Abnormality Found to Predict Childhood Leukemia Relapse
... less mature and possibly more resistant to the effects of drugs used to treat ALL. "These findings show how detailed analysis of leukemic cells using complementary techniques can enhance our understanding of the genetic basis of leukemia," said co-author Cheryl Willman, M.D., director and CEO, University of New ...Vical Pandemic Influenza Vaccines Achieve T-Cell Responses and Cross-Clade Reactivity in Humans
... therapeutics internally. In addition, the company collaborates with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product ...... therapeutics internally. In addition, the company collaborates with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product ...
Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial
... therapeutics internally. In addition, the company collaborates with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product ...U.S. Navy and U.S. Army to Develop Dengue DNA Vaccine Formulated With Vical's Vaxfectin(R) Adjuvant
... therapeutics internally. In addition, the company collaborates with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product ...... to significantly improve patients' quality of life," said Katie Hood, the Foundation's CEO. "Each one of our Pipeline Programs is a unique and complementary expression of our overarching mission -- identifying and enabling the critical ideas, teams and projects that will carry the field over the finish ...
Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System
... RB006 selectively and potently binds to and inhibits factor IXa, a protein that is critical to blood coagulation. The reversal agent, RB007, is a complementary nucleic acid that specifically binds to and neutralizes RB006. The amount of RB007 administered allows physicians to rapidly fine tune the ...... therapeutics internally. In addition, the company collaborates with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product ...
... to help clarify or validate other clinical findings. This test further strengthens our growing portfolio of proprietary, high-value diagnostics and complementary pharmaceutical products." IBS can be challenging to diagnose because it is a functional disease that is not associated with any visible abnormality ...
... companies, such as Baxter, GlaxoSmithKline (GSK), Merck Generics (part of Mylan Inc), UCB and Otsuka, as well as providing revenue streams, complementary products and critical mass. For further information, please visit Vectura's website at http://www.vectura.com Forward-Looking Statements This ...
... demonstrate the substantial anti-cancer effect of Angiolix, which we feel is comparable to Avastin yet achieved through a different and potentially complementary mechanism of action," stated Jeffrey B. Davis, President & CEO. "As stated previously, Access is actively seeking potential partners for the further ...
Napo Announces Positive Clinical Data Indicating Crofelemer, Could Effectively Treat Cholera
... and no drug related adverse events were observed in the cholera patients in this study. As a novel antisecretory agent, crofelemer represents a complementary mechanism to existing standard-of-care treatment of cholera, which consists of administering rehydration therapy and antibiotics, with the inherent ...Study Demonstrates That AHCC(R) Provides Immune Enhancement Against the West Nile Virus
... demonstrates its essential role for maintaining a healthy immune system," said Fred Pescatore, M.D., M.P.H., of the Center for Integrative and complementary Medicine, and medical director for the U.S. AHCC Research Association. Completed findings of the study were presented at the International AHCC ...... health. As a central component of the MLP, the Molecular Libraries Probe Production Centers Network (MLPCN) is a collaborative research network with complementary abilities that will enable screening of diverse types of assays and generation of chemical probes to address a wide range of biological ....
... therapeutics internally. In addition, the company collaborates with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product ...
... therapeutics internally. In addition, the company collaborates with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product ...
Genzyme and Isis Begin Second Phase 3 Trial Of Mipomersen
... lipids, including LDL cholesterol and triglycerides. The patent covers the use of both single-stranded and double-stranded (siRNA) antisense drugs complementary to any site of the mRNA of human apoB regardless of their chemistry or antisense mechanism of action. The allowance provides broad protection of the ...Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data
... therapeutics internally. In addition, the company collaborates with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product ...... after their launch due to their efficacy and high price point. The widespread use of these agents will depend, in part, on their safety and the complementary use of new diagnosis techniques that would permit patients to be diagnosed in the early stages of the disease, when disease-modifying therapies ...
Other ContentschichlorophyllchlorophyllchlorophyllchloroplastchloroplastchloroplastchromatinchromatinchromatinchromatinchromatinchromatinchromatidchromatidchromatographychromatographychromatographychromatographychromatographychromatographychromatographyciliumwalkingwalkingwalkingwalkingwalkingwalkingOther TagsOriginOriginOriginMoleculesMoleculesCocaineCocaineCocaineTrainTrainTrainTrainTrainTrainMemoriesMysteriousPheromone
(Date:11/30/2009)... ever thought the stress of seeing your extended f...news: a new research report in the December 2009 p... http://www.jleukbio.org ) shows that you might be...e study might lead to entirely new treatments that...is, and eczema under control. That,s because resea...
(Date:11/30/2009)... , VILNIUS, Lithuania, Nov. 30 /PRNewswire...com ), a provider of high-precision biometric iden...ades in the company,s core product line: VeriLook...cognition and MegaMatcher 3.1 SDK for large-scal...fication systems (AFIS). Expanded capabilities in ...
(Date:11/26/2009)...head sharks are some of the Ocean,s most distincti...ey have this strange head shape, says Michelle Mc...e reason is the shark,s vision. ,Perhaps their vis...ape, says McComb, giving the sharks excellent ste... to McComb, there were two schools of thought on t...
Breaking Biology News(10 mins):Seeing family for the holidays? Scientists discover how the stress might kill you 2New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 2New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 3Wide heads give hammerheads exceptional stereo view 2Largest Gift in History of Reed College and National Jewish Health Received from Author David Eddings 51929 1Largest Gift in History of Reed College and National Jewish Health Received from Author David Eddings 51929 2Largest Gift in History of Reed College and National Jewish Health Received from Author David Eddings 51929 3Largest Gift in History of Reed College and National Jewish Health Received from Author David Eddings 51929 4Facial Plastic Surgeon Dr Frank Fechner Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 51924 1Facial Plastic Surgeon Dr Frank Fechner Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 51924 2Facial Plastic Surgeon Dr Frank Fechner Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 51924 3Explorers Bounty Unveils New Line of Tribal Stone Crackers 51919 1Explorers Bounty Unveils New Line of Tribal Stone Crackers 51919 2(Date:12/2/2009)... ONDAMED® praised by Suzanne Somers in her N.Y... Cornwall, NY (PRWEB) December 2, 2009 --... Who Are Curing Cancer, And How to Prevent Getting...doctors who are successfully using the most innova...he body rather than tear it down. This is a subjec...
(Date:12/2/2009)... Leading medical device software engineering consu... 13485 certification. A relatively few medical dev...ually achieved ISO 13485 certification. Many medic...adhere to other ISO standards as well. However, it...gineering consulting firm to achieve the rigorous ...
(Date:12/2/2009)... 2 Targeted breast ultr...g lumps, is a safe, reliable and cost-effective al... 40, according to the findings of two studies pres...cal Society of North America (RSNA). ,, "By per...uce the number of expensive and avoidable invasive...
(Date:12/2/2009)...arge-scale clinical trial presented today at the a... America (RSNA) provide the first strong evidence ...women with dense breasts who are at elevated risk ...d that MRI is highly sensitive in depicting early ... with ultrasound in addition to mammography signif...
(Date:12/1/2009)...K, Dec. 1 Reportlinker.com announc...in its catalogue: ,, Emerging Clinical Trial ...g healthcare and regulatory environment ,, h...cal-Trial-Locations---India-Market-dynamics-and-th...tml ,, Over the last decade pharmaceutical and...
Breaking Medicine News(10 mins):Health News:Innovative Biofeedback Technology Wins By A "Knockout." 2Health News:Innovative Biofeedback Technology Wins By A "Knockout." 3Health News:Innovative Biofeedback Technology Wins By A "Knockout." 4Health News:Medical Device Software Engineering Consulting firm Full Spectrum Software Earns ISO 13485 Certification 2Health News:Targeted Breast Ultrasound Can Reduce Biopsies for Women Under Forty 2Health News:Annual screening with breast ultrasound or MRI could benefit some women 2Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 7[0] Innovative Biofeedback Technology Wins By A "Knockout." [0] Medical Device Software Engineering Consulting firm Full Spectrum Software Earns ISO 13485 Certification[0] Targeted Breast Ultrasound Can Reduce Biopsies for Women Under Forty[0] Annual screening with breast ultrasound or MRI could benefit some women[2] Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment
FantasticOriginMoleculesTracingCocaineRearingSelectingTrainMemoriesFirefightersArcherfishMysteriousPheromoneSensory
Other Tagsresembles 2resembles 3objects 2objects 3objects 4objects 5defibrillator 2inner 2inner 3inner 4inner 5inner 6inner 7inner 8inner 9importance 2importance 3importance 4importance 5importance 6importance 7importance 8importance 9importance 10
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |